Daily Archives: June 23, 2023 | LinksMedicus Free Medical News & Perspectives

WHO Report | Water, sanitation, hygiene, waste and electricity services in health care facilities

23 Jun, 2023 | 13:41h | UTC

Water, sanitation, hygiene, waste and electricity services in health care facilities: progress on the fundamentals – World Health Organization

News Release: Frontline health facilities faltering without water, sanitation, hygiene and electricity – WHO, UNICEF new report – World Health Organization

Commentary on Twitter (thread – click for more)

Better access to water, sanitation, hygiene & waste services in health facilities improve quality care and help prevent millions of deaths annually.

New WHO & @UNICEF Global Progress Report 2023 outlines how:
➡️ https://t.co/moyBs6yibC pic.twitter.com/Rv0P8DjzjA

— World Health Organization (WHO) (@WHO) June 13, 2023

Report | Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021

23 Jun, 2023 | 13:40h | UTC

Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 – The Lancet Haematology

News Release: Sickle cell disease is 11 times more deadly than previously recorded – Institute for Health Metrics and Evaluation

Commentary on Twitter (thread – click for more)

Ahead of #WorldSickleCellDay #WSCD23 we are publishing the first detailed global estimates on the burden of #sicklecell disease

Read it #openaccess https://t.co/pVlWZ6s1G4

The authors show that mortality linked to #sicklecell disease is higher than previously described? pic.twitter.com/WplWr0gXqJ

— The Lancet Haematology (@TheLancetHaem) June 16, 2023

RCT | Single-Dose VLA1553 Chikungunya vaccine shows high immunogenicity and seems safe

23 Jun, 2023 | 13:38h | UTC

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial – The Lancet

News Release: First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response – The Lancet

Commentary on Twitter

New: First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response. https://t.co/YSzV5oxXRc pic.twitter.com/rGL7A5eLAr

— The Lancet (@TheLancet) June 13, 2023

RCT | Time-lapse-based embryo selection does not improve pregnancy rates in IVF treatments

23 Jun, 2023 | 13:37h | UTC

Clinical outcomes of uninterrupted embryo culture with or without time-lapse-based embryo selection versus interrupted standard culture (SelecTIMO): a three-armed, multicentre, double-blind, randomised controlled trial – The Lancet (link to abstract – $ for full-text)

News Release: New IVF Method: more expensive, not more effective – Amsterdam UMC

Commentary on Twitter (thread – click for more)

Time-lapse monitoring is increasingly used to culture and select embryos for transfer in IVF. Yet there is insufficient evidence for superior clinical results.

A study evaluated whether the embryo selection method can increase clinical results. ?https://t.co/DFqgCFHZ55

— The Lancet (@TheLancet) May 3, 2023

Review | Evaluation and management of diabetes-related foot infections

23 Jun, 2023 | 13:36h | UTC

Evaluation and Management of Diabetes-related Foot Infections – Clinical Infectious Diseases

Guideline | Management of adrenal incidentalomas

23 Jun, 2023 | 13:33h | UTC

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors – European Journal of Endocrinology

#377 Adrenal Incidentalomas with Dr. William Young – The Curbsiders

[Abstract Only] Meta-Analysis: Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess

Cohort Study | Real-world data links valproate, antipsychotics to higher diabetes risk in bipolar disorder

23 Jun, 2023 | 13:32h | UTC

Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients – Bipolar Disorders

RCT | Dexmedetomidine administration shows promise in PTSD reduction for trauma surgery patients

23 Jun, 2023 | 13:30h | UTC

Effect of Dexmedetomidine on Posttraumatic Stress Disorder in Patients Undergoing Emergency Trauma Surgery: A Randomized Clinical Trial – JAMA Network Open

See also: Visual Abstract

Retrospective study | Increasing prevalence and severity of carbapenem-resistant Klebsiella Pneumoniae in ICUs

23 Jun, 2023 | 13:25h | UTC

Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study – BMJ Open

Consensus Paper | Primary prophylaxis of invasive fungal diseases in patients with hematological malignancies

23 Jun, 2023 | 13:23h | UTC

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) – Journal of Antimicrobial Chemotherapy

Cohort Study | Increased depression risk observed in first two years of oral contraceptive use

23 Jun, 2023 | 13:19h | UTC

Population-based cohort study of oral contraceptive use and risk of depression – Epidemiology and Psychiatric Sciences

News Release: New study links contraceptive pills and depression – Uppsala University

Commentary: Depression Risk May Rise During First Two Years of Oral Contraceptive Use – Psychiatric News Alert

Commentary on Twitter

Population-based cohort study of oral #contraceptive use and risk of #depression suggests that the use of OCs, particularly during the first 2 years, increases the risk of depression.https://t.co/spWuqCMKfW @therese_johans #mentalhealth #epidemiology pic.twitter.com/xMO0yiqPvt

— Epidemiology & Psychiatric Sciences (@EpiPsychSci) June 19, 2023

Stay Updated in Your Specialty